G6PC3 and pulmonary arterial hypertension: Our studies showed that G6PC3 was down-regulated in PAH at both the transcriptional and translational level (Fig 2c,d,f), suggesting that decreased expression of G6PC3 may be due to a decrease of G6P as a result of glucose being shuttled towards the sorbitol fructose pathway.